News / Publications

Recent News

EM Vivid Oct_edited_edited_edited.jpg

Dr. Enda Moran joins our leadership team as CEO of Matrivax

Matrivax is delighted to announce the appointment of Dr. Enda Moran PhD, MBA to the position of Chief Executive Officer.

October 12, 2021

Publications

Vaccine Front Cover_edited.jpg

Preclinical in vitro and in vivo profile of a highly-attenuated, broadly efficacious pneumolysin genetic toxoid

Thanawastien A, Joyce KE, Cartee RT, Haines, LA, Pelton SI, Tweten RK, Killeen KP. Preclinical in vitro and in vivo profile of a highly-attenuated, broadly efficacious pneumolysin genetic toxoid. Vaccine 2021; 39(11):1652-1660.

Online 2020: https://doi.org/10.1016/j.vaccine.2020.04.064 2020